Device Week Podcast: Episode 1
This article was originally published in The Gray Sheet
Gray Sheet reporters and editors discuss topics they are covering impacting the device and diagnostics community. This week, we address a restarted transcatheter aortic valve trial, FDA advisory panel reforms, 2014 device recall trends, FDA Decision Data tables and more.
You may also be interested in...
Liquid biopsy start-up Grail Inc. announced that a study of almost 6,700 participants found that its blood test could detect more than 50 types of cancer with a low false-positive rate. See what Minetta Liu, study co-lead author and a Mayo Clinic professor of oncology, had to say about the research.
Sanofi’s next-generation meningococcal vaccine, broader use of Bristol-Myers Squibb’s Reblozyl move toward approval; United Therapeutics foreshadows Trevyent regulatory difficulties.
Biopharma is working on a reputation renaissance as the public looks to industry for treatments and vaccines for the COVID-19 epidemic and drug pricing concerns take a back seat.